DanSamuelKaufmanMDPhD

Hematologic Oncology

Professor and Director of Cell Therapy. University of California-San Diego

Dr. Kaufman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9500 GILMAN DR.
MC 0695, Sanford Consortium
La Jolla, CA 92093
Phone+1 858-822-1777

University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1999 - 2002
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1996 - 1999
Mayo Clinic College of MedicineClass of 1996

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 2009

PubMed

4 citations
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells.
Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez, Dan S Kaufman
Cell Stem Cell. 2024-09-05
1 citations
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic Expansion.
Jong Hyuk Kim, Ashley J Schulte, Aaron L Sarver, Donghee Lee, Mathew G Angelos
Cancer Research Communications. 2024-06-11
1 citations
CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model.
Jiyoung Yun, Robert Saddawi-Konefka, Benjamin Goldenson, Riyam Al-Msari, Davide Bernareggi
Journal for Immunotherapy of Cancer. 2024-05-03

Abstracts/Posters

iPSC-Derived NK Cells Synergize with T Cells and Anti-PD-1 Antibody to Mediate Durable Anti-Tumor Responses In Vivo
Dan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Deletion of CISH in Human Pluripotent Stem Cell-Derived Natural Killer Cells Enhances Anti-Tumor Activity Via Metabolic Reprogramming
Dan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies
Dan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
FT538: Preclinical Development of an Off-the-Shelf Adoptive NK Cell Immunotherapy with Targeted Disruption of CD38 to Prevent Anti-CD38 Antibody-Mediated Fratricide an...
Dan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all

Treating HCC with Genetically Modified NK-Cell TherapyJuly 19th, 2024
Stem Cell-Derived Therapy Shows Promise Against Treatment-Resistant Liver CancerJuly 10th, 2024
State Stem Cell Agency Funds Three New UC San Diego ProjectsAugust 25th, 2021
Join now to see all

Stem Cell Therapy For Myocardial RepairNational Heart, Lung, And Blood Institute2011–2012
Osteogenic Repair From Human Pluripotent Stem CellsNational Institute Of Dental &Craniofacial Research2011
Stem Cell Biology Training ProgramEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
Midwestern Progenitor Cell ConsortiumNational Heart, Lung, And Blood Institute2009–2011
Hematopoietic Precursor Development From Human Embryonic Stem (ES) CellsNational Heart, Lung, And Blood Institute2007–2010
Hematopoietic Precursor Development From Human ES CellsNational Heart, Lung, And Blood Institute2006
Immunocompromised Mouse CoreNational Cancer Institute2005
In Vivo Potential Of Human ES Cell-Derived Blood CellsNational Heart, Lung, And Blood Institute2002–2004